• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性视网膜疾病是澳大利亚工作年龄段人群中最常见的致盲原因。

Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia.

机构信息

Centre for Ophthalmology and Visual Science (Incorporating Lions Eye Institute), The University of Western Australia, Nedlands, Australia.

Department of Ophthalmology, Royal Perth Hospital, Perth, Australia.

出版信息

Ophthalmic Genet. 2021 Aug;42(4):431-439. doi: 10.1080/13816810.2021.1913610. Epub 2021 May 3.

DOI:10.1080/13816810.2021.1913610
PMID:33939573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8315212/
Abstract

This study examined the frequency of inherited retinal diseases (IRDs) as the reason for blindness registrations over the last two decades and the demographic and clinical phenotypes of inherited retinal disease (IRD)-related registrations. Retrospective, observational study of individuals registered with a state-wide blind and vision-impaired registry. Low-vision or blindness-only (≤20/200 or ≤20°) certificates issued to children (0-15 years), working-age (16-64 years) and older-age (65 and older) adults were assessed. Sex and age distributions were examined for the top 20 reasons for certification. Demographic and clinical features of specific phenotypes of IRDs listed in the registry were examined. Amongst 11824 low-vision certificates issued between July 1995 and January 2017, 679 (5.7%) listed an IRD as the reason for registration. In individuals with blindness-only certification (N=4919), IRDs was the second most common diagnosis (8.3%), overtaking glaucoma (8.1%) and diabetic retinopathy (5.4%). IRD was the second most common reason for low-vision certification amongst children (11.6%) and the most common reason amongst working-age population (23.3%). The mean±SD age for IRD-related blindness-only certification was 46±20 years. The top three phenotypes of IRD-related low-vision certification were non-syndromic retinitis pigmentosa (54%), Stargardt disease (12%) and macular dystrophy (8%). Our findings of IRDs as a common cause of blindness in all ages justify continued funding for providing low-vision services and developing treatments for these conditions.

摘要

本研究调查了过去二十年中遗传性视网膜疾病(IRDs)作为失明登记的原因的频率,以及与遗传性视网膜疾病(IRD)相关的登记的人口统计学和临床表型。对在全州盲人和视力障碍登记处登记的个人进行回顾性观察研究。评估了发给儿童(0-15 岁)、工作年龄(16-64 岁)和老年(65 岁及以上)成年人的低视力或失明证书(≤20/200 或≤20°)。对前 20 个认证原因的性别和年龄分布进行了检查。检查了登记册中列出的特定 IRD 表型的人口统计学和临床特征。在 1995 年 7 月至 2017 年 1 月期间颁发的 11824 份低视力证书中,有 679 份(5.7%)将 IRD 列为登记的原因。在仅有失明认证的人群中(N=4919),IRD 是第二常见的诊断(8.3%),超过了青光眼(8.1%)和糖尿病视网膜病变(5.4%)。在儿童中(11.6%),IRD 是低视力认证的第二常见原因,在工作年龄人群中(23.3%),IRD 是最常见的原因。IRD 相关的仅有失明认证的平均年龄±SD 为 46±20 岁。IRD 相关的低视力认证的前三个表型是非综合征性视网膜色素变性(54%)、斯塔加特病(12%)和黄斑营养不良(8%)。我们发现 IRD 在所有年龄段都是失明的常见原因,这证明继续为这些疾病提供低视力服务和开发治疗方法是合理的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebd/8315212/8c385144fd75/IOPG_A_1913610_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebd/8315212/bf5d094e3dad/IOPG_A_1913610_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebd/8315212/76851a93a7bc/IOPG_A_1913610_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebd/8315212/8c385144fd75/IOPG_A_1913610_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebd/8315212/bf5d094e3dad/IOPG_A_1913610_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebd/8315212/76851a93a7bc/IOPG_A_1913610_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebd/8315212/8c385144fd75/IOPG_A_1913610_F0003_OC.jpg

相似文献

1
Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia.遗传性视网膜疾病是澳大利亚工作年龄段人群中最常见的致盲原因。
Ophthalmic Genet. 2021 Aug;42(4):431-439. doi: 10.1080/13816810.2021.1913610. Epub 2021 May 3.
2
Registered blindness and low vision in Kuwait.科威特的登记失明和视力低下情况。
Ophthalmic Epidemiol. 2005 Aug;12(4):251-7. doi: 10.1080/09286580591005813.
3
Trends in blind and low vision registrations in Taipei City.台北市盲人与视力低下登记趋势。
Eur J Ophthalmol. 2008 Jan-Feb;18(1):118-24. doi: 10.1177/112067210801800120.
4
Trends in the incidence and causes of severe visual impairment and blindness in children from Israel.以色列儿童严重视力损害和失明的发病率及病因趋势。
J AAPOS. 2015 Jun;19(3):260-5.e1. doi: 10.1016/j.jaapos.2015.04.002.
5
Blindness and visual impairment in Central Europe.中欧的失明和视力障碍。
PLoS One. 2022 Jan 13;17(1):e0261897. doi: 10.1371/journal.pone.0261897. eCollection 2022.
6
Assessing the diagnostic validity of a blind register.评估盲法登记的诊断准确性。
Clin Exp Ophthalmol. 2011 Aug;39(6):494-500. doi: 10.1111/j.1442-9071.2011.02509.x. Epub 2011 Mar 24.
7
Relative frequencies of inherited retinal dystrophies and optic neuropathies in Southern France: assessment of 21-year data management.法国南部遗传性视网膜营养不良和视神经病变的相对发病率:21年数据管理评估
Ophthalmic Epidemiol. 2013;20(1):13-25. doi: 10.3109/09286586.2012.737890.
8
A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC).以色列遗传性视网膜疾病联合会(IIRDC)对以色列遗传性视网膜疾病进行的全国性基因分析。
Hum Mutat. 2020 Jan;41(1):140-149. doi: 10.1002/humu.23903. Epub 2019 Sep 15.
9
Frequency and Genetic Spectrum of Inherited Retinal Dystrophies in a Large Dutch Pediatric Cohort: The RD5000 Consortium.荷兰大型儿科队列中遗传性视网膜营养不良的频率和遗传谱:RD5000 联盟。
Invest Ophthalmol Vis Sci. 2024 Aug 1;65(10):40. doi: 10.1167/iovs.65.10.40.
10
A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice.遗传性视网膜疾病的多学科诊疗方法:从诊断到初步治疗的叙述性综述,附有临床实践的投入。
Orphanet J Rare Dis. 2023 Jul 31;18(1):223. doi: 10.1186/s13023-023-02798-z.

引用本文的文献

1
RP1 Dual-AAV Gene Therapy Preserves Retinal Structure and Ameliorates Photoreceptor Degeneration in a Murine Model of Retinitis Pigmentosa.RP1双腺相关病毒基因疗法可保留视网膜结构并改善视网膜色素变性小鼠模型中的光感受器退化。
Invest Ophthalmol Vis Sci. 2025 Sep 2;66(12):29. doi: 10.1167/iovs.66.12.29.
2
Natural course of refractive errors in early onset inherited retinal diseases.早发性遗传性视网膜疾病中屈光不正的自然病程。
Eye (Lond). 2025 Sep 12. doi: 10.1038/s41433-025-03987-9.
3
Panel-Based Genetic Testing in a Consecutive Series of Individuals with Inherited Retinal Diseases in Australia: Identifying Predictors of a Diagnosis.

本文引用的文献

1
Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.临床视角:治疗 RPE65 相关的视网膜营养不良。
Mol Ther. 2021 Feb 3;29(2):442-463. doi: 10.1016/j.ymthe.2020.11.029. Epub 2020 Dec 3.
2
Association of Sex With Frequent and Mild ABCA4 Alleles in Stargardt Disease.性别与斯塔加特病中 ABCA4 等位基因的频繁和轻度关联。
JAMA Ophthalmol. 2020 Oct 1;138(10):1035-1042. doi: 10.1001/jamaophthalmol.2020.2990.
3
Recent trends in vision impairment certifications in England and Wales.英格兰和威尔士视力损伤认证的最新趋势。
澳大利亚一系列遗传性视网膜疾病患者的基于基因检测板的基因检测:确定诊断的预测因素
Genes (Basel). 2025 Jul 27;16(8):888. doi: 10.3390/genes16080888.
4
Stargardt's Disease: Molecular Pathogenesis and Current Therapeutic Landscape.斯塔加特病:分子发病机制与当前治疗现状
Int J Mol Sci. 2025 Jul 21;26(14):7006. doi: 10.3390/ijms26147006.
5
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders.RP1、BEST1和PROM1相关视网膜疾病双等位基因与单等位基因变异的不同表现
Int J Mol Sci. 2025 Jul 10;26(14):6615. doi: 10.3390/ijms26146615.
6
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.用于罕见眼科疾病的纳米囊泡给药系统:进展、挑战与未来方向
AAPS PharmSciTech. 2025 Jul 23;26(7):197. doi: 10.1208/s12249-025-03159-8.
7
Quantification of Optical Coherence Tomography Features in >3500 Patients with Inherited Retinal Disease Reveals Novel Genotype-Phenotype Associations.对3500多名遗传性视网膜疾病患者的光学相干断层扫描特征进行量化分析,揭示了新的基因型-表型关联。
medRxiv. 2025 Jul 3:2025.07.03.25330767. doi: 10.1101/2025.07.03.25330767.
8
Characterizing Inner Retinal Changes in End-Stage Inherited Retinal Diseases That Might be Suitable for Optogenetic Therapies.表征终末期遗传性视网膜疾病中可能适用于光遗传学疗法的视网膜内层变化。
Transl Vis Sci Technol. 2025 Jun 2;14(6):2. doi: 10.1167/tvst.14.6.2.
9
Patient-Reported Social Impact of Molecularly Confirmed Retinitis Pigmentosa.患者报告的分子确诊视网膜色素变性的社会影响。
J Clin Med. 2025 May 6;14(9):3229. doi: 10.3390/jcm14093229.
10
Compendium of Clinical Variant Classification for 2,246 Unique Variants to Clarify Variant Pathogenicity in Stargardt Disease Using a Modified ACMG/AMP Framework.使用改良的美国医学遗传学与基因组学学会(ACMG)/分子病理学协会(AMP)框架对2246个独特变体进行临床变异分类的纲要,以阐明Stargardt病中的变异致病性
Hum Mutat. 2023 Dec 26;2023:6815504. doi: 10.1155/2023/6815504. eCollection 2023.
Eye (Lond). 2020 Jul;34(7):1271-1278. doi: 10.1038/s41433-020-0864-6. Epub 2020 Apr 14.
4
Late-Onset Stargardt Disease Due to Mild, Deep-Intronic ABCA4 Alleles.迟发性斯塔加特病由轻度、深内含子 ABCA4 等位基因引起。
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4249-4256. doi: 10.1167/iovs.19-27524.
5
Inherited retinal disease in Norway - a characterization of current clinical and genetic knowledge.挪威遗传性视网膜疾病——当前临床和遗传知识的特征描述。
Acta Ophthalmol. 2020 May;98(3):286-295. doi: 10.1111/aos.14218. Epub 2019 Aug 19.
6
Estimation of impact of mediated inherited retinal disease on quality of life and the potential benefits of gene therapy.中介遗传性视网膜疾病对生活质量的影响评估和基因治疗的潜在获益。
Br J Ophthalmol. 2019 Nov;103(11):1610-1614. doi: 10.1136/bjophthalmol-2018-313089. Epub 2019 Jan 18.
7
VISUAL ACUITY IN PATIENTS WITH STARGARDT DISEASE AFTER AGE 40.40 岁以上斯特格病患者的视力。
Retina. 2018 Dec;38(12):2387-2394. doi: 10.1097/IAE.0000000000001903.
8
Prevalence, Age at Diagnosis, Mortality, and Cause of Death in Retinitis Pigmentosa in Korea-A Nationwide Population-based Study.韩国视网膜色素变性的患病率、诊断年龄、死亡率及死因——一项基于全国人口的研究
Am J Ophthalmol. 2017 Apr;176:157-165. doi: 10.1016/j.ajo.2017.01.014. Epub 2017 Jan 24.
9
Prevalence of generalized retinal dystrophy in Denmark.丹麦广泛性视网膜营养不良的患病率。
Ophthalmic Epidemiol. 2014 Aug;21(4):217-23. doi: 10.3109/09286586.2014.929710. Epub 2014 Jun 25.
10
A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010.1999 - 2000年与2009 - 2010年英格兰和威尔士工作年龄成年人(16 - 64岁)失明认证原因的比较。
BMJ Open. 2014 Feb 12;4(2):e004015. doi: 10.1136/bmjopen-2013-004015.